Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Patel Anish. Director active across 1 company, notably Enliven Therapeutics, Inc.. Aggregated, 28 reports have been published. Breakdown: 0 buy · 20 sells. Total volume traded: €3.1m. History available since 22 December 2023. The latest transaction was disclosed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Patel Anish
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4,875 shares@ US$15.1355.4% of flowCommon StockSEC:0001209191-24-002190:0
25 of 28 declarations
About Patel Anish
Patel Anish is a declarant and Chief Operating Officer at Enliven Therapeutics, Inc. The declarant has 28 filings in total. Among the sampled recent filings, they cover the period from 2023-02-27 to 2026-02-17 and show only sales for a total of EUR 3069915.